About 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine
5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine (PubChem CID 175007186) has the molecular formula C28H32ClF3N10O2
and a molecular weight of 633.08 g/mol. Its IUPAC name is 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine.
Molecular Properties
| Compound Name | 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine |
| PubChem CID | 175007186 |
| Molecular Formula | C28H32ClF3N10O2 |
| Molecular Weight | 633.08 g/mol |
| Exact Mass | 632.24 |
| IUPAC Name | 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine |
| SMILES | CC(Cn1cnnn1)Oc1cc(-c2cnc(Nc3cn(C4(N5CCOCC5)CCCCC4)nc3C(F)(F)F)nc2)ccc1Cl |
| InChI | InChI=1S/C28H32ClF3N10O2/c1-19(16-41-18-35-38-39-41)44-24-13-20(5-6-22(24)29)21-14-33-26(34-15-21)36-23-17-42(37-25(23)28(30,31)32)27(7-3-2-4-8-27)40-9-11-43-12-10-40/h5-6,13-15,17-19H,2-4,7-12,16H2,1H3,(H,33,34,36) |
| InChIKey | BPOKRJUBWXWTSV-UHFFFAOYSA-N |
| XLogP | 5.16 |
| TPSA | 120.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
| MW ≤ 500 | 633.08 |
| LogP ≤ 5 | 5.16 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Analyze 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine?
The IUPAC name of 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine (CID 175007186) is 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine.
What is the SMILES notation for 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine?
The canonical SMILES for 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine is CC(Cn1cnnn1)Oc1cc(-c2cnc(Nc3cn(C4(N5CCOCC5)CCCCC4)nc3C(F)(F)F)nc2)ccc1Cl.
What is the InChIKey of 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine?
The InChIKey is BPOKRJUBWXWTSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H32ClF3N10O2/c1-19(16-41-18-35-38-39-41)44-24-13-20(5-6-22(24)29)21-14-33-26(34-15-21)36-23-17-42(37-25(23)28(30,31)32)27(7-3-2-4-8-27)40-9-11-43-12-10-40/h5-6,13-15,17-19H,2-4,7-12,16H2,1H3,(H,33,34,36).
What are the key properties of 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine?
5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine has a molecular weight of 633.08 g/mol, XLogP of 5.16, 9 rotatable bonds, 1 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-chloro-3-[1-(tetrazol-1-yl)propan-2-yloxy]phenyl]-N-[1-(1-morpholin-4-ylcyclohexyl)-3-(trifluoromethyl)pyrazol-4-yl]pyrimidin-2-amine is sourced from PubChem (CID 175007186), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).